Hey everyone, I am new to this message board, but have been long on AMBS for awhile. I am a medical school student and like the potential of the MANF molecule, but have serious concerns regarding the success of the LymPro test. I just do not see how a company with such an important diagnostic tool such as the LymPro test could be valued at as little as 11 cents. A successful test to diagnose Alzheimer's is crucial to the understanding of the disease and key to finding a cure. If what Gerald says is true about the commercialization of LymPro beginning at the end of this year, it does not make any sense why AMBS is only 11 cents. If LymPro is real and commercializes the stock will literally explode. Why have no other pharmaceutical companies looked into purchasing LymPro outright? Right now I just feel like most people trading out there have no faith in LymPro, as well as most people in the scientific community. I want to believe AMBS has struck gold with LymPro, but right now I believe it will not become a successful diagnostic tool and they will strike out. Can anyone alleviate my concerns?